2022 Stronger - PH341 - Prediction Software Helps Reduce Hypotension and Improve Outcomes - On Demand

During surgery, blood pressure management varies among clinicians across various health care settings. This variation is not benign because hypotension is common and can lead to severe complications, such as myocardial and kidney injury, delirium, and even mortality. Also, hypotension increases hospital costs. Hypotension prediction index software alerts clinicians to a future hypotensive event, while a standardized treatment algorithm guides the therapeutic intervention. In a large multicenter clinical trial, use of this proactive, data-driven system reduced hypotension. Such innovative technology can reduce care variation and improve surgical patient outcomes.

Target Audience

  • Nurses
  • Pharmacists
  • Physicians
  • Other Healthcare Professionals

Learning Objectives

  • Articulate the relationship between hypotension and postoperative outcomes for surgical patients.
  • Articulate the relationship between hypotension and increased costs for surgical patients.
  • Explain the role of hypotension prediction index software in reducing hypotension in the surgical patient, thus improving patient outcomes and decreasing costs.

Additional Information

AttachmentSize
PDF icon PH341.pdf4.08 MB
Course summary
Available credit: 
  • 0.50 ACPE Pharmacist
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 General CE - Attendance
Course opens: 
09/21/2022
Course expires: 
09/21/2023

Faculty

Kamal Maheshwari, MD, MPH, Director, Center for Perioperative Intelligence, Associate Professor of Anesthesiology, Cleveland Clinic, Cleveland, OH

 

Disclosure

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
FDA Off-Label Use
 
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 
Disclosure Statements
 

Existence of Relevant Financial Relationships

Kamal Maheshwari, MD, MPH, speaker for this educational activity, is a consultant for Dynocardia, Phillips and Edwards Lifesciences, and has received research funding from Edwards Lifesciences.

All relevant financial relationships listed for this individual have been mitigated.

Absence of Relevant Financial Relationships

All others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 
 

Credit Types

Nurses (CNE)

Vizient, Inc. designates this enduring material for a maximum of 0.5 ANCC contacts hours.

Pharmacists (CPE)

Vizient, Inc. designates this enduring material for a maximum of 0.5 contact hours for Pharmacists. 

Universal Activity Number: JA0006103-0000-22-094-H04-P

Physicians (CME)

Vizient, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals (General CE Credit)

Vizient, Inc. will award a maximum of 0.5 contact hours to all other healthcare professionals who successfully complete the activity. These individuals will receive a Certificate of Participation indicating the maximum credits available.

Many state licensing boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

 

Available Credit

  • 0.50 ACPE Pharmacist
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 General CE - Attendance
Please login or register to take this course.

Select the Obtain Credit button to access the activity.